Adimmune Corporation (4142.TW) TAI
17.20
+0(+0.00%)
Currency In TWD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.98B |
| Enterprise Value | 8.62B |
| P/E Ratio | -24.82 |
| PEG Ratio | 0.17 |
| Price/Sales Ratio | 5.14 |
| Price/Book Ratio | 1.52 |
| Enterprise/Revenue | 5.79 |
| Enterprise/EBITDA | -26.3 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.21 |
| Operating Margin | -0.21 |
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -0.06 |
Income Statement
| Revenue | 1.4B |
| Revenue/Share | 3.35 |
| Gross Profit | 288.49M |
| EBITDA | -144.69M |
| Net Income | -239.89M |
| Diluted EPS | -0.57 |
Balance Sheet
| Total Cash | 1.84B |
| Total Cash/Share | 4.38 |
| Total Debt | 2.72B |
| Total Debt/Equity | 0.57 |
| Current Ratio | 2.1 |
| Book Value Per Share | 11.5 |
Price History
| 52-Week Change | -6.27 |
| 52-Week High | 22.5 |
| 52-Week Low | 15.9 |
| Moving Average 50 Days | 17.95 |
| Moving Average 200 Days | 18.58 |
Statistics
| Average Volume | 1.32M |
| Shares Outstanding | 421.51M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1053:1000 |
| Last Split Date | April 18, 2019 |
